| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |